Skip to main content

Value Stock - Dividend - Research Selection


Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


LeMaitre: Balance Sheet Ready To Unlock Risk Capital, Reaffirm Buy

LeMaitre missed top line estimates secondary to FX headwinds and market challenges. Read more to learn why we reaffirm our Buy rating on LMAT stock.

Dividend Champion, Contender, And Challenger Highlights: Week Of November 27

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to see the companies' dividends, upcoming ex-dividend dates, and upcoming pay dates.

Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?

LeMaitre Vascular, Inc. ( NASDAQ:LMAT ), is not the largest company out there, but it saw a double-digit share price...

THB US Micro Cap Fund Q3 2022 Quarterly Report

The THB US Micro Cap Fund returned 2.1% in AUD (net of fees) in Q3 2022. Click here to read the full fund letter.

Is This Underfollowed Dividend Stock a Buy?

Rising interest rates and fears of a global recession spooked investors, crushing many growth stocks in 2022. Shares of medical device maker LeMaitre Vascular (NASDAQ: LMAT) are down just 12% so far in 2022. The company was helped by the continued strong demand for medical devices even as the economy started slowing.

LeMaitre to Present at Upcoming Investor Conferences

BURLINGTON, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences. David Roberts, President, will present at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at the Lotte New York Palace in New York City. The company’s presentation is scheduled at 3:10 PM ET. He is also scheduled to present at the Sidoti Small-Cap Virtual Conference on Thursday, December 8, 20

LMAT Makes Bullish Cross Above Critical Moving Average

In trading on Tuesday, shares of LeMaitre Vascular Inc (LMAT) crossed above their 200 day moving average of $46.78, changing hands as high as $47.06 per share - LeMaitre Vascular Inc shares are currently trading up about 1.8% on the day. - LMAT.

Ex-Dividend Reminder: LeMaitre Vascular, Affiliated Managers Group and Berkshire Hills Bancorp

dividend channel,LMAT,AMG,BHLB,

Dividend Champion, Contender, And Challenger Highlights: Week Of November 13

Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more see companies with upcoming ex-dividend dates and upcoming pay dates.

LeMaitre Vascular Third Quarter 2022 Earnings: Misses Expectations

LeMaitre Vascular ( NASDAQ:LMAT ) Third Quarter 2022 Results Key Financial Results Revenue: US$39.0m (up 1.7% from 3Q...